FACTORS ASSOCIATED WITH SUSTAINED REMISSION IN RHEUMATOID ARTHRITIS IN PATIENTS TREATED WITH ANTI-TUMOUR NECROSIS FACTOR: A SYSTEMATIC REVIEW

被引：0
|
作者：
Hamann, Philip [1 ]
Holland, Richard [2 ,3 ]
Hyrich, Kimme [4 ]
Pauling, John [2 ,3 ]
Shaddick, Gavin [5 ]
Nightingale, Alison [1 ]
McHugh, Neil [1 ]
机构：
[1] Univ Bath, Pharm & Pharmacol, Bath BA2 7AY, Avon, England
[2] Royal Natl Hosp Rheumat Dis, Rheumatol, Upper Borough Walls, Bath BA1 1RL, Avon, England
[3] Royal United Hosp, Bath BA1 3NG, Avon, England
[4] Univ Manchester, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England
[5] Univ Bath, Math Sci, Bath BA2 7AY, Avon, England
来源：
RHEUMATOLOGY | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
093
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [1] Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor
    Hamann, Philip
    Holland, Richard
    Hyrich, Kimme
    Pauling, John D.
    Shaddick, Gavin
    Nightingale, Alison
    McHugh, Neil
    ARTHRITIS CARE & RESEARCH, 2017, 69 (06) : 783 - 793
  • [2] Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients
    Hamann, Philip D. H.
    Pauling, John D.
    McHugh, Neil
    Shaddick, Gavin
    Hyrich, Kimme
    Maiden, Nicola
    Price, Tom
    Hopkinson, Neil
    O'Reilly, Sheila
    Hordon, Lesley
    Griffiths, Ian
    Porter, Duncan
    Capell, Hilary
    Hassell, Andy
    Benitha, Romela
    Choy, Ernest
    Walsh, David
    Emery, Paul
    Knight, Susan
    Bruce, Ian
    Taggart, Allister
    Scott, David
    Harrison, Bev
    Thompson, Paul
    McCrae, Fiona
    Goodfellow, Rhian
    Bukhari, Marwan
    Klimiuk, Peter
    Kitas, George
    Jubb, Ronald
    Abernethy, Rikki
    Clarke, Shane
    Green, Sandra
    Sanders, Paul
    Coulson, Amanda
    RHEUMATOLOGY, 2019, 58 (12) : 2162 - 2169
  • [3] The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
    Harrold, Leslie R.
    Reed, George W.
    Kremer, Joel M.
    Curtis, Jeffrey R.
    Solomon, Daniel H.
    Hochberg, Marc C.
    Greenberg, Jeffrey D.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 430 - 436
  • [4] Gene expression profiling of rheumatoid arthritis patients treated with anti-tumour necrosis factor
    Coenen, Marieke J. H.
    Toonen, Erik J. M.
    Batliwalla, Franak
    van Riel, Piet L. C. M.
    Kievit, Wietske
    Veltman, Joris A.
    Eijsbouts, Agnes M. M.
    Gilissen, Christian F. H. A.
    Damle, Aarti
    Scheffer, Hans
    Radstake, Timoth R. D. J.
    Gregersen, Peter K.
    Barrera, Pilar
    Franke, Barbara
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S615 - S616
  • [5] Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis
    Puechal, X.
    Miceli-Richard, C.
    Mejjad, O.
    Lafforgue, P.
    Marcelli, C.
    Solau-Gervais, E.
    Steinfeld, S.
    Villoutreix, C.
    Treves, R.
    Mariette, X.
    Guillevin, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (06) : 880 - 884
  • [6] The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
    Askling, Johan
    Dixon, Will
    CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (02) : 138 - 144
  • [7] Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis
    Alcorn, Nicola
    Tierney, Ann
    Wu, Olivia
    Gilmour, Harper
    Madhok, Rajan
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) : 1571 - 1571
  • [8] Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis
    Popa, C
    Netea, MG
    Radstake, T
    Van der Meer, JWM
    Stalenhoef, AFH
    van Riel, PLCM
    Barerra, P
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 303 - 305
  • [9] Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents
    Russell, AS
    Maksymowych, WP
    de Silva, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (12) : 1807 - 1807
  • [10] Anti-tumour necrosis factor α therapy modulates ghrelin in patients with severe rheumatoid arthritis
    Gonzalez-Gay, M. A.
    Garcia-Unzueta, M. T.
    Berja, A.
    Vazquez-Rodriguez, T. R.
    Gonzalez-Juanatey, C.
    de Matias, J. M.
    Martin, J.
    Dessein, P. H.
    Llorca, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (11) : 1644 - 1646
12345